(ESI), or with dithranol as matrix (MALDI-TOF). Molecular
modeling was carried out using Chem 3D Pro version 5.0 for Mac
(CambridgeSoft, Cambridge, USA, 1999) and MM2 force field
computations.
CH), 6.18 (d, 4JH,H = 2.2 Hz, 2 H, o-Ar), 6.44 (t, 4JH,H = 2.2 Hz,
1
1 H, p-Ar), 7.3–7.4 ppm (m, 10H, Ph). 13C{ H} NMR (CDCl3):
d 11.0 (pz-Me5), 13.7 (pz-Me3), 40.2 (CH2), 69.8 (PhCH2O), 71.6
(CH), 101.2 (p-Ar), 106.3 (pz-C4), 108.1 (o-Ar), 127.4 and 128.5
(o- and m-Ph), 127.9 (p-Ph), 136.8 (ipso-Ph), 138.7 (ipso-Ar), 139.6
5
3
=
(pz-C ), 147.9 (pz-C ), 159.7 (m-Ar). IR (KBr): m 1558 (s, C N),
Syntheses
−1
=
1595 and 1453 (s, C C), 1261 and 1026 cm (vs, C–O–C). MS
(ESI+ in MeOH/0.1% HCOOH): m/z 507 [M + H]+, 411 [M −
Me2pz]+, 315 [M − 2Me2pz-H]+.
Preparation
of
(trimethylsilyl)bis(3,5-dimethylpyrazolyl)-
methane [Me3SiCH(3,5-Me2pz)2] (1). nBuLi (3.1 mL, 1.6 M in
hexanes, 4.96 mmol) was slowly added, from a funnel equipped
with a bubbler, to a solution of H2C(3,5-Me2pz)2 (1.00 g,
4.9 mmol) in THF (40 mL) at −78 ◦C and the mixture was stirred
for 2 h at that temperature. An excess of SiMe3Cl was then added
(0.76 mL, 6.0 mmol) and the reaction mixture was allowed to
warm to room temp. and stirred overnight. After removal of the
solvent under vacuum the residue was extracted into pentane
(2 × 15 mL), and compound 1 was isolated as a pale-yellow solid
by evaporation of the filtrates to dryness under vacuum. Yield:
1.098 g (81%). Anal. Calc. for C14H24N4Si (276.46): C, 60.82; H,
8.75; N, 20.27%. Found: C, 60.72; H, 8.39; N, 20.05%. 1H NMR
(CDCl3): d 0.20 (s, 9 H, SiMe3), 1.94 (s, 6 H, pz-Me3), 2.16 (s, 6
Preparation of G2-CH(3,5-Me2pz)2 (4). This compound was
prepared according to the procedure described above for 2, from
LiCH(3,5-Me2pz)2 (0.87 mmol), prepared in situ, and dendritic
wedge G2–Br (0.7 g, 0.87 mmol) in THF. Ligand 4 was purified
by addition of pentane to a stirred diethyl ether solution, which
caused it to precipitate as an off-white solid. Yield: 0.632 g (78%).
Anal. Calc. for C60H58N4O6 (931.14): C, 77.40; H, 6.28; N, 6.02%.
Found: C, 76,98; H, 6.37; N, 5.91%. 1H NMR (CDCl3): d 2.01 (s,
6 H, pz-Me3), 2.20 (s, 6 H, pz-Me5), 3.78 (d, JH,H = 7.3 Hz, 2 H,
CH2), 4.80 (s, 4 H, ArCH2O), 5.01 (s, 8 H, PhCH2O), 5.71 (s, 2 H,
pz-H4), 6.13 (t, JH,H = 7.3 Hz, 1 H, CH), 6.17 (d, 4JH,H = 2.0 Hz, 2
1
H, pz-Me5), 5.74 (s, 2 H, pz-H4), 5.87 ppm (s, 1 H, CH). 13C{ H}
H, G0-o-Ar), 6.44 (t, 4JH,H = 2.0 Hz, 1 H, G0-p-Ar), 6.54 (t, 4JH,H
=
NMR (CDCl3): d −1.2 (SiMe3), 10.8 (pz-Me5), 13.5 (pz-Me3),
4
2.1 Hz, 2 H, G1-p-Ar), 6.61 (d, JH,H = 2.1 Hz, 4 H, G1-o-Ar),
68.5 (CH), 106.1 (pz-C4), 139.7 (pz-C5), 146.6 ppm (pz-C3). IR
1
7.3–7.4 ppm (m, 20H, Ph). 13C{ H} NMR (CDCl3): d 11.0 (pz-
−1
=
=
Me5), 13.8 (pz-Me3), 40.2 (CH2), 69.7 (ArCH2O), 70.1 (PhCH2O),
71.7 (CH), 101.3 (G0-p-Ar), 101.4 (G1-p-Ar), 106.2 (G1-o-Ar),
106.3 (pz-C4), 108.1 (G0-o-Ar), 127.5 and 128.6 (o- and m-Ph),
128.0 (p-Ph), 136.7 (ipso-Ph), 138.8 (G1-ipso-Ar), 139.3 (pz-C5),
139.6 (G0-ipso-Ar), 147.9 (pz-C3), 159.6 (G0-m-Ar), 160.1 ppm
(KBr): m 1617 (m, C C), 1550 cm (s, C N). MS (ESI+ in
MeOH/0.1% HCOOH): m/z 277 [M + H]+, 181 [M − Me2pz]+,
85 [M − 2Me2pz-H]+.
Preparation of (benzyl)bis(3,5-dimethylpyrazolyl)methane [G0-
CH(3,5-Me2pz)2] (2). nBuLi (3.1 mL, 1.6 M in hexanes,
4.96 mmol) was added dropwise to a solution of H2C(3,5-Me2pz)2
(1.00 g, 4.9 mmol) in THF (15 mL) at −78 ◦C. The reaction mixture
was stirred for 2 h at that temperature, then PhCH2Br was added
(0.6 mL, 5.0 mmol) and the solution allowed to warm to room
temp. The solvent was removed under vacuum, the crude solid
dissolved in diethyl ether (30 mL) and washed with water (2 ×
20 mL), and the organic layer dried with MgSO4. Removal of the
volatiles followed by recrystallization from pentane led to ligand
2 as a white solid. Yield: 1.138 g (79%). Anal. Calc. for C18H22N4
(294.40): C, 73.44; H, 7.53; N, 19.03%. Found: C, 73.21; H, 7.47;
N, 18.95%. 1H NMR (CDCl3): d 2.03 (s, 6 H, pz-Me3), 2.20 (s, 6 H,
pz-Me5), 3.87 (d, JH,H = 7.3 Hz, 2 H, CH2), 5.71 (s, 2 H, pz–H4),
6.20 (t, JH,H = 7.3 Hz, 1 H, CH), 6.95 (m, 2 H, m-Ph), 7.17 ppm (m,
=
=
(G1-m-Ar). IR (KBr): m 1559 (s, C N), 1595 and 1451 (vs, C C),
1293 and 1262 (s, C–O–Cas), 1156 and 1040 cm−1 (vs, C–O–Cs).
MS (ESI+ in MeOH/0.1% HCOOH): m/z 931 [M + H]+, 835
[M − Me2pz]+, 739 [M − 2Me2pz-H]+.
Preparation of G3-CH(3,5-Me2pz)2 (5). Dendritic wedge 5 was
prepared according to the procedure described above for 2, starting
from LiCH(3,5-Me2pz)2 (0.6 mmol), prepared in situ, and G3–
Br (1.0 g, 0.6 mmol) in THF. Purification was carried out by
addition of pentane to a stirred toluene solution, which caused
precipitation as an off-white solid. Yield: 0.775 g (72%). Anal.
Calc. for C116H106N4O14 (1780.14): C, 78.27; H, 6.00; N, 3.15%.
Found: C, 78.14; H, 6.09; N, 2.90%. 1H NMR (CDCl3): d 2.00 (s, 6
H, pz-Me3), 2.20 (s, 6 H, pz-Me5), 3.79 (d, JH,H = 7.3 Hz, 2 H, CH2),
4.81 (s, 4 H, G1-ArCH2O), 4.94 (s, 8 H, G2-ArCH2O), 5.00 (s, 16
H, PhCH2O), 5.71 (s, 2 H, pz-H4), 6.13 (t, JH,H = 7.3 Hz, 1 H, CH),
6.17 (d, 4JH,H = 2.2 Hz, 2 H, G0-o-Ar), 6.44 (t, 4JH,H = 2.2 Hz, 1 H,
1
3 H, o- and p-Ph). 13C{ H} NMR (CDCl3): d 11.2 (pz-Me5), 14.0
(pz-Me3), 40.1 (CH2), 72.2 (CH), 106.2 (pz-C4), 126.6 (p-Ph), 128.1
and 129.1 (o- and m-Ph), 136.3 (ipso-Ph), 139.2 (pz-C5), 147.6 (pz-
3
−1
=
=
C ). IR (KBr): m 1557 (s, C N), 1604 (m, C C), 1453 cm (s,
G0-p-Ar), 6.51 (t, 4JH,H = 2.2 Hz, 2 H, G1-p-Ar), 6.54 (t, 4JH,H
=
+
=
C C). MS (ESI+ in MeOH/0.1% HCOOH): m/z 295 [M + H] ,
4
2.2 Hz, 4 H, G2-p-Ar), 6.59 (d, JH,H = 2.2 Hz, 4 H, G1-o-Ar),
199 [M − Me2pz]+.
4
6.66 (d, JH,H = 2.2 Hz, 8 H, G2-o-Ar), 7.3–7.4 ppm (m, 40H,
1
Preparation of G1-CH(3,5-Me2pz)2 (3). This compound was
prepared according to the procedure described above for 2, from
LiCH(3,5-Me2pz)2 (1.3 mmol), prepared in situ, and dendritic
wedge G1–Br (0.50 g, 1.3 mmol) in THF (20 mL). The resulting
yellow oil was stirred with pentane (15 mL) for several hours to
give compound 3 as a white solid. Yield: 0.50 g (76%). Anal. Calc.
for C32H34N4O2 (506.65): C, 75.86; H, 6.76; N, 11.06%. Found: C,
75.69; H, 6.80; N, 10.88%. 1H NMR (CDCl3): d 2.02 (s, 6 H, pz-
Me3), 2.21 (s, 6 H, pz-Me5), 3.79 (d, JH,H = 7.3 Hz, 2 H, CH2), 4.87
(s, 4 H, PhCH2O), 5.73 (s, 2 H, pz–H4), 6.12 (t, JH,H = 7.3 Hz, 1 H,
Ph). 13C{ H} NMR (CDCl3): d 11.0 (pz-Me5), 13.7 (pz-Me3), 40.2
(CH2), 69.8 (G1-ArCH2O), 70.0 (G2-ArCH2O), 70.1 (PhCH2O),
71.7 (CH), 101.2 (G0-p-Ar), 101.4 (G1-p-Ar), 101.6, (G2-p-Ar),
106.2 (overlapping G1-o-Ar, G2-o-Ar and pz-C4), 108.2 (G0-o-
Ar), 127.6 and 128.6 (o- and m-Ph), 128.0 (p-Ph), 136.8 (ipso-
Ph), 138.9 (G1-ipso-Ar), 139.1 (G2-ipso-Ar), 139.3 (pz-C5), 139.6
(G0-ipso-Ar), 147.9 (pz–C3), 159.7 (G0-m-Ar), 160.1 (G1-m-Ar),
=
160.2 ppm (G2-m-Ar). IR (KBr): m 1560 (s, C N), 1595 and 1452
(vs, C C), 1295 (s, C-O-Casym), 1155 and 1051 cm−1 (vs, C–O–Cs).
=
MS (ESI+ in MeOH/0.1% HCOOH): m/z 1781 [M + H]+.
5386 | Dalton Trans., 2006, 5379–5389
This journal is
The Royal Society of Chemistry 2006
©